160
Participants
Start Date
October 28, 2013
Primary Completion Date
December 1, 2015
Study Completion Date
August 11, 2017
Rituximab
Up to 6 cycles (total of 8 doses administered by intravenous infusion): 375 mg/m2 on Day 1 of Cycle 1, 500 mg/m2 on Day 15 of Cycle 1 (Weeks 1-4); 500 mg/m2 on Day 1 and Day 15 of Cycle 2 (Weeks 5-8); and 500 mg/m2 on Day 1 of Cycles 3-6 (Weeks 9-24).
Ibrutinib
420 mg capsules administered by mouth daily until disease progression or unacceptable toxicity, whichever occurs first.
Concord
Gosford
Heidelberg
Perth
Tweed Heads
Beijing
Chendu
Fuzhou
Guangzhou
Jinan
Nanjing
Qingdao
Shanghai
Suzhou
Tianjin
Unk Hangzhou
Wuhan
Xi'an
Johor Bahru
Kuala Lumpur
Malacca
Subang Jaya
Changhua
Kaohsiung City
Tainan City
Taipei
Collaborators (1)
Pharmacyclics LLC.
INDUSTRY
Janssen Research & Development, LLC
INDUSTRY